Via The Lancet: Hormonal contraceptive prescriptions in Colombia and Zika virus. Excerpt:
Neither the recommendations made by the Colombian Ministry of Health in January, 2016, nor the first reports of domestic cases in Colombia in October, 2015, have generated increased contraceptive use, as no evidence exists of adherence to the proposal to reduce the risk of malformations in the country with the second highest number of reported cases of Zika virus infection in the Americas.
Several factors might explain the absence of a response, as suggested by Mónica Roa in her letter to The Lancet (Feb 27, p 843), which suggests that 56% of pregnancies in Latin America are unplanned as a result of poor quality sex education, low access to contraception, the presence of cultural barriers, and other factors that lead to a large number of women who do not have control over their sexual and reproductive lives.
The Zika virus outbreak has highlighted the poor quality of sexual health programmes in Colombia and Latin America, where thousands of women (especially those who are poor and have reduced access to health services) are at greater risk of infection and complications during pregnancy than women in other areas of the world.
Therefore, improvement of equitable access of all women of childbearing age to high quality sexual education, contraception, and safe maternity is crucial.